Biocytogen Pharmaceuticals signs a License Agreement With Pheon Therapeutics

Exclusive License Agreement for an Oncological Target Antibody to Develop Best-In-Class ADC

Biocytogen Pharmaceuticals (Beijing) Co., Ltd., a global biotech company focusing on the discovery of novel antibody therapeutics, yesterday announced an antibody license agreement with Pheon Therapeutics (Pheon), a leading Antibody-Drug Conjugate (ADC) specialist developing next-generation ADCs for a wide range of hard-to-treat cancers. Under the terms of the agreement, Pheon will develop and commercialize an […]

Centerspace announces CEO succession of Mark Decker, Jr. by Anne Olson

Centerspace, Inc. announced yesterday the transition of Mark Decker, Jr., the Company’s President and CEO since 2017. As part of the succession plan, the Board of Directors has appointed Anne Olson, the Company’s Executive Vice President, Chief Operating Officer, and General Counsel, to succeed Mr. Decker as President and CEO effective March 31, 2023, at which time she will […]